Relevance of the Core 70 and IL-28B polymorphism and response-guided therapy of peginterferon alfa-2a ± ribavirin for chronic hepatitis C of Genotype 1b: A multicenter randomized trial, ReGIT-J study

导出原文传递

翻译打印收藏纠错

作者： Nishiguchi,S. ^[1] ; Enomoto,H. ^[2] ; Aizawa,N. ^[3] ; Nishikawa,H. ^[4] ; Osaki,Y. ^[5] ; Tsuda,Y. ^[6] ; Higuchi,K. ^[7] ; Okazaki,K. ^[8] ; Seki,T. ; Kim,S.R. ; Hongo,Y. ; Jyomura,H. ; Nishida,N. ; Kudo,M.

作者单位： Division of Hepatobiliary and Pancreatic Disease, Department of Internal Medicine, Hyogo College of ^[1] Department of Gastroenterology and Hepatology, Osaka Red Cross Hospital, Osaka, Japan ^[2] Department of Internal Medicine, Kobe Asahi Hospital, Hyogo, Japan ^[3] Department of Gastroenterology and Hepatology, Hirakata City Hospital, Osaka, Japan ^[4] Second Department of Internal Medicine, Osaka Medical College, Osaka, Japan ^[5] Wakakoukai Medical Clinic, Osaka, Japan ^[6] Department of Gastroenterology and Hepatology, Kansai Medical University, Osaka, Japan ^[7] Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka, Japan ^[8]

关键词 Chronic hepatitis C IL-28B Peginterferon alfa-2a Response-guided therapy Ribavirin

发布时间 2014-05-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交